Evidence map›Paper›PMID 37766093›Full record

ArticleVaccines2023

Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study.

Ui Yoon Choi, Ki Hwan Kim, Hye-Kyung Cho, Dong Ho Kim, Sang Hyuk Ma, Young Youn Choi, Chun Soo Kim, Maria Rosario Capeding, Ilya Angelica Rochin Kobashi, Hun Kim and 4 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 3 countries.

Ui Yoon ChoiDepartment of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
Ki Hwan KimDepartment of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 21431, Republic of Korea.
Hye-Kyung ChoDepartment of Pediatrics, Gachon University College of Medicine, Incheon 21936, Republic of Korea.
Dong Ho KimDepartment of Pediatrics, Korea Cancer Center Hospital, Seoul 01812, Republic of Korea.
Sang Hyuk MaDepartment of Pediatrics, Changwon Fatima Hospital, Changwon 51394, Republic of Korea.
Young Youn ChoiDepartment of Pediatrics, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
Chun Soo KimDepartment of Pediatrics, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.ORCID 0000-0003-3888-334X
Maria Rosario CapedingDepartment of Microbiology, Research Institute for Tropical Medicine, Manila 1781, Philippines.
Ilya Angelica Rochin KobashiCentro de Investigacion Clinica del Pacifico, Acapulco 39680, Mexico.
Hun KimSK Bioscience, Seongnam 13494, Republic of Korea.
Ji Hwa RyuSK Bioscience, Seongnam 13494, Republic of Korea.
Su Jeen LeeSK Bioscience, Seongnam 13494, Republic of Korea.
Ho Keun ParkSK Bioscience, Seongnam 13494, Republic of Korea.
Jong-Hyun KimDepartment of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon 16247, Republic of Korea.ORCID 0000-0001-8641-7904
Korea Research Institute of Bioscience and Biotechnology · KRCatholic University of Korea · KRCentro Universitario del Pacífico Sur · MXChonnam National University Hospital · KRGachon University · KRKeimyung University · KRResearch Institute for Tropical Medicine · PHThe Catholic University of Korea Incheon St. Mary's Hospital · KRThe Catholic University of Korea St. Vincent's Hospital · KR

Funding

SK Bioscience 2023
6 · The paper itself

Abstract

Korean manufacturers have developed a new varicella vaccine, NBP608. This phase 3, randomized, double-blind, multicenter study aimed to compare the immunogenicity and safety of NBP608 in healthy children to those of Varivax

Indexed as

childrenclinical trialimmunogenicitysafetyvaccinevaricella

Identifiers

PMID37766093
PMCPMC10537027
OpenAlexW4386134209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.